Joanne Bryce

WiTricity Corp. engages in the designs, development, manufactures, and marketing of technology for wireless energy transfer. It offers products to the consumer electronics, automotive, Industrial and medical markets. The company was founded by Peter H. Fisher, John D. Joannopoulos, Andre Kurs, Aristeidis Karalis, and Marin Soljacic in 2007 and is headquartered in Watertown, MA.

Jingle Networks, Inc. designs call advertising software products; provides directory assistance services. It offers solution to network operators, adverting agencies, brand marketers and small businesses. The company was founded in October 2005 and is headquartered in San Francisco, CA.

Narrative Communications Corp. develops and distributes high-impact advertising and multimedia streaming solutions for the Web.

Part of Cornerstone OnDemand, Inc., Aimtech Corp. develops and markets software for creation and deployment of interactive multimedia applications. The company is based in Nashua, NH. Aimtech was acquired by Click2Learn, Inc. on July 01, 1997.

Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL.

Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA.

Gemini Therapeutics, Inc. is a clinical-stage precision medicine company. It is developing novel therapeutic compounds to treat genetically defined, age-related macular degeneration. The company was founded by Johanna Seddon, Paul Barlow and Andrew Herbert on March 3, 2015 and is headquartered in Cambridge, MA.

Quartet Medicine, Inc. is a biotechnology company that develops treatments for chronic pain and inflammation by restoring tetrahydrobiopterin homeostasis inneuronal and inflammatory cells. Its drug discovery efforts are fully structurally enabled and are focused on demonstrating changes in BH4-related biomarkers that correlate with drug pharmacokinetics and efficacy in preclinical animal models. The company was founded by Kevin Pojasek, Kai Johnsson, and Clifford Woolf in 2013 and is headquartered in Cambridge, MA.